{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:03:00Z","timestamp":1794542580616,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370055"],"award-info":[{"award-number":["82370055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2020YFC2008600"],"award-info":[{"award-number":["2020YFC2008600"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Multidisciplinary Cooprative Diagnosis and Treatment Capacity Building Project for Major Diseases","award":["Lung Cancer, ID: z027002"],"award-info":[{"award-number":["Lung Cancer, ID: z027002"]}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for the Central Universities of Central South University","doi-asserted-by":"crossref","award":["2025ZZTS0238"],"award-info":[{"award-number":["2025ZZTS0238"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduate","doi-asserted-by":"publisher","award":["CX20250358"],"award-info":[{"award-number":["CX20250358"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06300-3","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:36:48Z","timestamp":1782405408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TRIM32-mediated ABI2 downregulation promotes anoikis resistance and metastasis by regulating EMT in lung adenocarcinoma"],"prefix":"10.1007","volume":"83","author":[{"given":"Yongting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5577-8202","authenticated-orcid":false,"given":"Qiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"9","key":"6300_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP (2023) The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol 20(9):624\u2013639","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"6300_CR2","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1080\/1061186X.2025.2489986","volume":"33","author":"N Orooji","year":"2025","unstructured":"Orooji N, Babaei S, Fadaee M, Abbasi-Kenarsari H, Eslami M, Kazemi T et al (2025) Novel therapeutic approaches for non-small cell lung cancer: an updated view. J Drug Target 33(8):1306\u20131321","journal-title":"J Drug Target"},{"issue":"3","key":"6300_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.trecan.2025.01.005","volume":"11","author":"S Waliany","year":"2025","unstructured":"Waliany S, Lin JJ, Gainor JF (2025) Evolution of first versus next-line targeted therapies for metastatic non-small cell lung cancer. Trends Cancer 11(3):245\u2013257","journal-title":"Trends Cancer"},{"issue":"1","key":"6300_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12964-023-01183-4","volume":"21","author":"Y Dai","year":"2023","unstructured":"Dai Y, Zhang X, Ou Y, Zou L, Zhang D, Yang Q et al (2023) Anoikis resistance\u2013protagonists of breast cancer cells survive and metastasize after ECM detachment. Cell Commun Signal 21(1):190","journal-title":"Cell Commun Signal"},{"key":"6300_CR5","doi-asserted-by":"publisher","first-page":"217750","DOI":"10.1016\/j.canlet.2025.217750","volume":"624","author":"P Shaw","year":"2025","unstructured":"Shaw P, Dey Bhowmik A, Gopinatha Pillai MS, Robbins N, Dwivedi SKD, Rao G (2025) Anoikis resistance in Cancer: Mechanisms, therapeutic strategies, potential targets, and models for enhanced understanding. Cancer Lett 624:217750","journal-title":"Cancer Lett"},{"key":"6300_CR6","doi-asserted-by":"publisher","first-page":"101099","DOI":"10.1016\/j.drup.2024.101099","volume":"75","author":"Y Wang","year":"2024","unstructured":"Wang Y, Cheng S, Fleishman JS, Chen J, Tang H, Chen Z-S et al (2024) Targeting anoikis resistance as a strategy for cancer therapy. Drug Resist Updat 75:101099","journal-title":"Drug Resist Updat"},{"issue":"1","key":"6300_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41419-025-07703-z","volume":"16","author":"Y Numata","year":"2025","unstructured":"Numata Y, Fujii T, Toda C, Okumura T, Manabe T, Takeda N et al (2025) Digoxin promotes anoikis of circulating cancer cells by targeting Na+\/K+-ATPase \u03b13-isoform. Cell Death Dis 16(1):373","journal-title":"Cell Death Dis"},{"issue":"4","key":"6300_CR8","doi-asserted-by":"publisher","first-page":"e18113","DOI":"10.1111\/jcmm.18113","volume":"28","author":"K Shen","year":"2024","unstructured":"Shen K, Xia W, Wang K, Li J, Xu W, Liu H et al (2024) ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT\/FBLN2 axis. J Cell Mol Med 28(4):e18113","journal-title":"J Cell Mol Med"},{"issue":"12","key":"6300_CR9","doi-asserted-by":"publisher","first-page":"e32626","DOI":"10.1016\/j.heliyon.2024.e32626","volume":"10","author":"GI Solyanik","year":"2024","unstructured":"Solyanik GI, Kolesnik DL, Prokhorova IV, Yurchenko OV, Pyaskovskaya ON (2024) Mitochondrial dysfunction significantly contributes to the sensitivity of tumor cells to anoikis and their metastatic potential. Heliyon 10(12):e32626","journal-title":"Heliyon"},{"issue":"8","key":"6300_CR10","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/mc.23933","volume":"64","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Li X, Liu F, Li J, Yang K, Xu S et al (2025) Downregulation of HTRA1 Promotes EMT and Anoikis Resistance in Colorectal Cancer via Activation of Hippo\/YAP1 Pathway by Facilitating LATS2 Degradation. Mol Carcinog 64(8):1330\u20131346","journal-title":"Mol Carcinog"},{"issue":"5","key":"6300_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41419-022-04890-x","volume":"13","author":"L-N Wang","year":"2022","unstructured":"Wang L-N, Zhang Z-T, Wang L, Wei H-X, Zhang T, Zhang L-M et al (2022) TGF-\u03b21\/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2\/STAT3 and SHP2\/Grb2 signaling pathways. Cell Death Dis 13(5):472","journal-title":"Cell Death Dis"},{"issue":"139","key":"6300_CR12","doi-asserted-by":"publisher","first-page":"re6","DOI":"10.1126\/scisignal.3139re6","volume":"3","author":"J Colicelli","year":"2010","unstructured":"Colicelli J (2010) ABL tyrosine kinases: evolution of function, regulation, and specificity. Sci Signal 3(139):re6","journal-title":"Sci Signal"},{"issue":"7","key":"6300_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.tplants.2010.04.006","volume":"15","author":"AS Raghavendra","year":"2010","unstructured":"Raghavendra AS, Gonugunta VK, Christmann A, Grill E (2010) ABA perception and signalling. Trends Plant Sci 15(7):395\u2013401","journal-title":"Trends Plant Sci"},{"issue":"3","key":"6300_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1006\/mcne.2000.0865","volume":"16","author":"KD Courtney","year":"2000","unstructured":"Courtney KD, Grove M, Vandongen H, Vandongen A, LaMantia AS, Pendergast AM (2000) Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system. Mol Cell Neurosci 16(3):244\u2013257","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"6300_CR15","doi-asserted-by":"publisher","first-page":"10667","DOI":"10.1038\/s41598-020-67781-1","volume":"10","author":"R Wang","year":"2020","unstructured":"Wang R, Liao G, Wang Y, Tang DD (2020) Distinctive roles of Abi1 in regulating actin-associated proteins during human smooth muscle cell migration. Sci Rep 10(1):10667","journal-title":"Sci Rep"},{"issue":"1","key":"6300_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12967-024-05324-2","volume":"22","author":"H Li","year":"2024","unstructured":"Li H, Liu J, Lai J, Su X, Wang X, Cao J et al (2024) The HHEX-ABI2\/SLC17A9 axis induces cancer stem cell-like properties and tumorigenesis in HCC. J Transl Med 22(1):537","journal-title":"J Transl Med"},{"issue":"1","key":"6300_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12935-024-03407-0","volume":"24","author":"L Lv","year":"2024","unstructured":"Lv L, Li S, Kang J, Li Y, Zhao N, Ye D et al (2024) Inhibition of ABI2 ubiquitination-dependent degradation suppresses TNBC cell growth via down-regulating PI3K\/Akt signaling pathway. Cancer Cell Int 24(1):222","journal-title":"Cancer Cell Int"},{"issue":"1","key":"6300_CR18","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12885-021-08388-1","volume":"21","author":"RC Ramaker","year":"2021","unstructured":"Ramaker RC, Hardigan AA, Gordon ER, Wright CA, Myers RM, Cooper SJ (2021) Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition. BMC Cancer 21(1):632","journal-title":"BMC Cancer"},{"issue":"28","key":"6300_CR19","doi-asserted-by":"publisher","first-page":"e2400673","DOI":"10.1002\/adhm.202400673","volume":"13","author":"B Dong","year":"2024","unstructured":"Dong B, Gu Y, Sun X, Wang X, Zhou Y, Rong Z et al (2024) Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer. Adv Healthc Mater 13(28):e2400673","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"6300_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13046-022-02381-7","volume":"41","author":"Y Yu","year":"2022","unstructured":"Yu Y, Song Y, Cheng L, Chen L, Liu B, Lu D et al (2022) CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells. J Exp Clin Cancer Res 41(1):188","journal-title":"J Exp Clin Cancer Res"},{"issue":"14","key":"6300_CR21","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-07-6231","volume":"68","author":"S Kano","year":"2008","unstructured":"Kano S, Miyajima N, Fukuda S, Hatakeyama S (2008) Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2. Cancer Res 68(14):5572\u20135580","journal-title":"Cancer Res"},{"key":"6300_CR22","doi-asserted-by":"publisher","first-page":"108522","DOI":"10.1016\/j.pharmthera.2023.108522","volume":"250","author":"SU Khan","year":"2023","unstructured":"Khan SU, Fatima K, Malik F, Kalkavan H, Wani A (2023) Cancer metastasis: Molecular mechanisms and clinical perspectives. Pharmacol Ther 250:108522","journal-title":"Pharmacol Ther"},{"issue":"5","key":"6300_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10585-022-10172-9","volume":"39","author":"SU Khan","year":"2022","unstructured":"Khan SU, Fatima K, Malik F (2022) Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis. Clin Exp Metastasis 39(5):715\u2013726","journal-title":"Clin Exp Metastasis"},{"key":"6300_CR24","first-page":"19","volume":"14","author":"J Wang","year":"2022","unstructured":"Wang J, Luo Z, Lin L, Sui X, Yu L, Xu C et al (2022) Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies. Cancers (Basel) 14:19","journal-title":"Cancers (Basel)"},{"key":"6300_CR25","doi-asserted-by":"publisher","first-page":"111457","DOI":"10.1016\/j.cellsig.2024.111457","volume":"124","author":"X Gao","year":"2024","unstructured":"Gao X, Zhang Z, Li Q, Tai G, Wang Z (2024) GDF15 enhances anoikis resistance and metastasis of gastric cancer through protective autophagy. Cell Signal 124:111457","journal-title":"Cell Signal"},{"key":"6300_CR26","doi-asserted-by":"publisher","first-page":"102544","DOI":"10.1016\/j.redox.2022.102544","volume":"58","author":"T Tian","year":"2022","unstructured":"Tian T, Lu Y, Lin J, Chen M, Qiu H, Zhu W et al (2022) CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis. Redox Biol 58:102544","journal-title":"Redox Biol"},{"issue":"1","key":"6300_CR27","doi-asserted-by":"publisher","first-page":"2535774","DOI":"10.1080\/15384047.2025.2535774","volume":"26","author":"L Fan","year":"2025","unstructured":"Fan L, Zhou Y, Liu S, Zhuo X, Qu L, Wu D et al (2025) NR4A3 regulates anoikis resistance and metastasis of bladder cancer through EWSR1. Cancer Biol Ther 26(1):2535774","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"6300_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s12672-024-01293-6","volume":"15","author":"L Yin","year":"2024","unstructured":"Yin L, Zhang Z, Yan Z, Yan Q (2024) Multicenter cohort analysis of anoikis and EMT: implications for prognosis and therapy in lung adenocarcinoma. Discov Oncol 15(1):462","journal-title":"Discov Oncol"},{"key":"6300_CR29","doi-asserted-by":"publisher","first-page":"1600546","DOI":"10.3389\/fcell.2025.1600546","volume":"13","author":"M Wang","year":"2025","unstructured":"Wang M, Cheng L, Qi K, Wang H, Li X (2025) Identification of prognostic biomarkers related to epithelial-mesenchymal transition and anoikis in hepatocellular carcinoma using transcriptomics and single-cell sequencing. Front Cell Dev Biol 13:1600546","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"6300_CR30","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.7150\/jca.106029","volume":"16","author":"C Zeng","year":"2025","unstructured":"Zeng C, Xu C, Wei Y, Ma F, Wang Y (2025) Training and experimental validation a novel anoikis- and epithelial\u2013mesenchymal transition-related signature for evaluating prognosis and predicting immunotherapy efficacy in gastric cancer. J Cancer 16(4):1078\u20131100","journal-title":"J Cancer"},{"issue":"29","key":"6300_CR31","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/s41388-023-02749-9","volume":"42","author":"RA Sample","year":"2023","unstructured":"Sample RA, Nogueira MF, Mitra RD, Puram SV (2023) Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer. Oncogene 42(29):2237\u20132248","journal-title":"Oncogene"},{"key":"6300_CR32","doi-asserted-by":"crossref","unstructured":"Sinha D, Saha P, Samanta A, Bishayee A (2020) Emerging concepts of hybrid epithelial-to-mesenchymal transition in cancer progression. Biomolecules. 10(11):1561","DOI":"10.3390\/biom10111561"},{"issue":"4","key":"6300_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4062\/biomolther.2022.066","volume":"30","author":"GJ Kang","year":"2022","unstructured":"Kang GJ, Park JH, Kim HJ, Kim EJ, Kim B, Byun HJ et al (2022) PRR16\/Largen Induces Epithelial-Mesenchymal Transition through the Interaction with ABI2 Leading to the Activation of ABL1 Kinase. Biomol Ther (Seoul) 30(4):340\u2013347","journal-title":"Biomol Ther (Seoul)"},{"issue":"1","key":"6300_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.18632\/aging.102618","volume":"12","author":"J Huang","year":"2020","unstructured":"Huang J, Qin Y, Yang C, Wan C, Dai X, Sun Y et al (2020) Downregulation of ABI2 expression by EBV-miR-BART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN\/SLUG signaling. Aging 12(1):340\u2013358","journal-title":"Aging"},{"key":"6300_CR35","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.2147\/DDDT.S482340","volume":"18","author":"C Weng","year":"2024","unstructured":"Weng C, Jin R, Jin X, Yang Z, He C, Zhang Q et al (2024) Exploring the Mechanisms, Biomarkers, and Therapeutic Targets of TRIM Family in Gastrointestinal Cancer. Drug Des Devel Ther 18:5615\u20135639","journal-title":"Drug Des Devel Ther"},{"key":"6300_CR36","doi-asserted-by":"publisher","first-page":"156394","DOI":"10.1016\/j.metabol.2025.156394","volume":"174","author":"J Wang","year":"2025","unstructured":"Wang J, Wang Q, Li X, Cai Q, Bi Y, Xu C et al (2025) Emerging roles of TRIM in metabolic regulation. Metabolism 174:156394","journal-title":"Metabolism"},{"key":"6300_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jare.2023.01.011","volume":"54","author":"J Gu","year":"2023","unstructured":"Gu J, Chen J, Xiang S, Zhou X, Li J (2023) Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape. J Adv Res 54:147\u2013179","journal-title":"J Adv Res"},{"issue":"49","key":"6300_CR38","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/s41388-023-02873-6","volume":"42","author":"L Sun","year":"2023","unstructured":"Sun L, Chen Y, Xia L, Wang J, Zhu J, Li J et al (2023) TRIM69 suppressed the anoikis resistance and metastasis of gastric cancer through ubiquitin\u2013proteasome-mediated degradation of PRKCD. Oncogene 42(49):3619\u20133632","journal-title":"Oncogene"},{"issue":"1","key":"6300_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yexcr.2018.04.013","volume":"368","author":"P Guo","year":"2018","unstructured":"Guo P, Qiu Y, Ma X, Li T, Ma X, Zhu L et al (2018) Tripartite motif 31 promotes resistance to anoikis of hepatocarcinoma cells through regulation of p53-AMPK axis. Exp Cell Res 368(1):59\u201366","journal-title":"Exp Cell Res"},{"issue":"4","key":"6300_CR40","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1002\/jcb.27798","volume":"120","author":"H Yin","year":"2018","unstructured":"Yin H, Li Z, Chen J, Hu X (2018) Expression and the potential functions of TRIM32 in lung cancer tumorigenesis. J Cell Biochem 120(4):5232\u20135243","journal-title":"J Cell Biochem"},{"key":"6300_CR41","doi-asserted-by":"publisher","first-page":"7841","DOI":"10.2147\/OTT.S176689","volume":"11","author":"Y Du","year":"2018","unstructured":"Du Y, Zhang W, Du B, Zang S, Wang X, Mao X et al (2018) TRIM32 overexpression improves chemoresistance through regulation of mitochondrial function in non-small-cell lung cancers. Onco Targets Ther 11:7841\u20137852","journal-title":"Onco Targets Ther"},{"key":"6300_CR42","doi-asserted-by":"crossref","unstructured":"Xu J, Liu W, Chen L, Zhang J, Zhang D, Huang X et al (2025) TRIM32 promotes anoikis resistance and metastasis in NSCLC by degrading CHEK2 to enhance IL-6 secretion. Cell Death Differ 33(1):126\u2013139","DOI":"10.1038\/s41418-025-01559-8"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06300-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06300-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06300-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:02:22Z","timestamp":1789383742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06300-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6300"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06300-3","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committees of Xiangya Hospital and carried out in accordance with the principles of the Declaration of Helsinki. All participants have given informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article has been authorized by all authors and agreed to be published.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"331"}}